$AME

Hermance David F. sold $1.7M of AME

Hermance David F. (PRESIDENT - ELECTROMECHANICAL) sold 6,608 shares of AMETEK INC/ (AME) at $254.00 ($1.68M total) on 2026-08-07.

Original reporting
SEC EDGAR · Hermance David F.
Published Aug 10, 2026, 8:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AME
Neutral
medium confidence
Mentioned
$AME
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMENeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings by an officer (PRESIDENT - ELECTROMECHANICAL).

02

Market read

Traders may note the insider selling activity, but there is no accompanying fundamental catalyst in the text.

03

What to watch

The filing does not state motivations, tax considerations, or whether other insiders sold/bought around the same time, limiting inference value.

Relevance 6/10Novelty 3/10Timing: filed 2026-08-10, transaction dated 2026-08-07

Background

The article is an SEC Form 4 insider transaction disclosure for AMETEK (AME).

Company-level read

Ticker impact

$AMENeutralMedium confidence
Context

SEC Form 4 shows AMETEK officer Hermance David F. sold 6,608 shares at $254 on 2026-08-07 for about $1.68M.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless paired with other news.

Evidence & confidence

The filing is a Form 4 insider transaction. It provides transaction details but no new operational, financial, or regulatory information about AME.

Market effects

No clear sector read-through from a single insider sale without accompanying company guidance or events.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted as less “planned” selling, but insider sales are often driven by diversification or personal liquidity needs.

Key entities

  • AME

    AMETEK Inc., the company whose insider transaction was filed.

  • Hermance David F.

    Officer (PRESIDENT - ELECTROMECHANICAL) who sold shares via open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMEHighAI 9/10

AMETEK Completes Acquisition of Indicor Instrumentation

AMETEK, Inc. (NYSE: AME) completed its $5.0 billion acquisition of Indicor Instrumentation. The deal adds businesses that design and manufacture mission-critical industrial and scientific solutions. Indicor Instrumentation is expected to contribute $350 million to AMETEK's 2026 sales and be modestly accretive to earnings. The acquisition aligns with AMETEK's growth strategies and market focus.

$AMEHighAI 9/10

AMETEK Raises 2026 Outlook After Earnings Climb 17%

AMETEK (NYSE: AME) raised its 2026 outlook after Q2 results. Second-quarter adjusted earnings rose 17% to $2.09 per diluted share, with sales up 15% to $2.04 billion and orders up 28%. AMETEK now expects 2026 adjusted earnings of $8.20 to $8.30 per share and sales up about 10% from 2025.

$AMEHighAI 9/10

AMETEK (AME) Q2 2026 Earnings Call Transcript

AMETEK (AME) reported Q2 2026 net sales of $2.04B, up 15% year over year, with 10% organic growth. Adjusted EPS was $2.09, up 17%, above guidance of $1.96 to $2.00. Total orders were $2.3B, up 28%, backlog $4.11B. Full-year sales guidance rose about 10% and adjusted EPS to $8.20-$8.30.

$AMEMed

Segment Demand and Strategic Acquisitions Propel Growth

AMETEK (NYSE: AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year over year, beating Wall Street expectations. Non-GAAP EPS was $2.09, 4.8% above consensus. Management cited organic growth, rising orders and backlog of $4.11 billion, and contributions from acquisitions. Full-year guidance was raised, supported by AI, defense, and power grid demand.

$AMEMedAI 8/10

AMETEK, Inc. Q2 2026 Earnings Call Summary

AMETEK reported Q2 2026 momentum driven by multi-year infrastructure build-outs for AI, semiconductors, and power. Organic sales growth accelerated, with a record $4.11B backlog and about 80% expected to ship in 12 months. Core EMG margins rose 290 bps. Full-year 2026 organic sales guidance was raised to mid-to-high single digits; Indicor Instrumentation acquisition of $5B expected to close in H2 with 10% to 12% synergies.